Rothia mucilaginosa pneumonia diagnosed by quantitative cultures and intracellular organisms of bronchoalveolar lavage in a lymphoma patient

Annals of Laboratory Medicine

Volumn 33, Issue 2, 2013, Pages 145-149

  Cho, Eun Jung ^a   Sung, Heungsup ^a   Park, Sook Ja ^a   Kim, Mi Na ^a   Lee, Sang Oh ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Bronchoalveolar lavage; Intracellular organisms; Low respiratory tract infections; Pneumonia; Quantitative culture; Rothia mucilaginosa

Indexed keywords

EID: 84876150697     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2013.33.2.145     Document Type: Article

References (24)

1. Becker K and von Eiff C. Staphylococcus, Micrococcus and other catalase-positive cocci. In: Becker K, Christof von EIFF, Bernard KA, Carroll KC, and Versalovic J, ed. Manual of clinical microbiology. 10th ed. Washington DC: American Society for Microbiology, 2011:308-30.
2. Rubin SJ, Lyons RW, Murcia AJ. Endocarditis associated with cardiac catheterization due to a Gram-positive coccus designated Micrococcus mucilaginosus incertae sedis. J Clin Microbiol 1978;7:546-9.
3. Faiad G, Singh M, Narasimhan A, Mendez M, Shama S, Nassar N. Rothia mucilaginosa life threatening infections in non-neutropenic hosts. Open J Intern Med 2011;1:68-71.
4. Ascher DP, Zbick C, White C, Fischer GW. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991;13:1048-52.
5. Treviño García-Zabarte A, Quintás A, Varela E, López-Paz JM, Jato A, et al. Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia. Eur J Clin Microbiol Infect Dis 1998;17:505-7.
6. Korsholm TL, Haahr V, Prag J. Eight cases of lower respiratory tract infection caused by Stomatococcus mucilaginosus . Scand J Infect Dis 2007;39:913-7.
7. Lambotte O, Debord T, Soler C, Roué R. Pneumonia due to Stomatococcus mucilaginosus in an AIDS patient: case report and literature review. Clin Microbiol Infect 1999;5:112-4.
8. Sánchez-Carrillo C, Cercenado E, Cibrián F, Bouza E. Stomatococcus mucilaginosus pneumonia in a liver-transplant patient. Clin Microbiol Newsl 1995;16:150-1.
9. Cunniffe JG, Mallia C, Alcock PA. Stomatococcus mucilaginosus lower respiratory tract infection in a patient with AIDS. J Infect 1994;29:327-30.
10. Clinical Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline 2nd ed, M45-A2. Wayne, PA: Clinical Laboratory Standards Institute, 2010:18-9.
11. Cantral DE, Tape TG, Reed EC, Spurzem JR, Rennard SI, Thompson AB. Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med 1993;95:601-7.
12. Allaouchiche B, Jaumain H, Dumontet C, Motin J. Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid? Chest 1996;110:1558-65.
13. Torres A, El-Ebiary M, Fábregas N, Gonzáilez J, de la Bellacasa JP, Hernández C, et al. Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia. Thorax 1996;51:378-84.
14. Solé-Violán J, Rodríguez de Castro F, Rey A, Martí-González JC, Cabrera-Navarro P. Usefulness of microscopic examination of intracellular organisms in lavage fluid in ventilator-associated pneumonia. Chest 1994;106:889-94.
15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32.
16. Garcia LS and Isenberg HD, ed. Clinical microbiology procedures handbook. 3rd ed. Washington DC: ASM Press, 2010:1:3.11.2.173.11.2.20-7.
17. von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995;39:268-70.
18. von Eiff C and Peters G. In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients. Eur J Clin Microbiol Infect Dis 1998;17:890-2.
19. Skogen PG, Kolmannskog S, Bergh K. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child. Clin Microbiol Infect 2001;7:39-42.
20. McWhinney PH, Kibbler CC, Gillespie SH, Patel S, Morrison D, Hoffbrand AV, et al. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis 1992;14:641-6.
21. Chomarat M, Vital MG, Flandrois JP. Susceptibility to aminoglycosides of 63 strains of Stomatococcus mucilaginosus isolated from sputum. Zentralbl Bakteriol 1991;276:63-7.
22. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-Second Informational supplement, M100-S22. Wayne, PA: Clinical Laboratory Standards Institute, 2012:70-9.
23. Capitano B, Mattoes HM, Shore E, O'Brien A, Braman S, Sutherland C, et al. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest 2004;125:965-73.
24. Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, et al. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs 2002;62:13-59.